-
1دورية أكاديمية
المؤلفون: D'Incecco, A, Andreozzi, M., Ludovini, V., Rossi, E., Capodanno, A., Landi, L., Tibaldi, C., Minuti, G., Salvini, J., Coppi, E., Chella, A., Filice, M. E., Tornillo, L., Incensati, R. M., Sani, S., Crinò, L., Terracciano, L., Cappuzzo, F., FONTANINI, GABRIELLA
المساهمون: D'Incecco, A, Andreozzi, M., Ludovini, V., Rossi, E., Capodanno, A., Landi, L., Tibaldi, C., Minuti, G., Salvini, J., Coppi, E., Chella, A., Fontanini, Gabriella, Filice, M. E., Tornillo, L., Incensati, R. M., Sani, S., Crinò, L., Terracciano, L., Cappuzzo, F.
مصطلحات موضوعية: non-small-cell lung cancer, PD-1, PD-L1, tyrosine kinase inhibitor, Adult, Aged, 80 and over, Antigens, CD274, Carcinoma, Non-Small-Cell Lung, Cohort Studie, Female, Human, Immunohistochemistry, Lung Neoplasm, Male, Middle Aged, Programmed Cell Death 1 Receptor, Retrospective Studie, Cancer Research, Oncology, Medicine (all)
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25349974; info:eu-repo/semantics/altIdentifier/wos/WOS:000348280900015; volume:112; issue:1; firstpage:95; lastpage:102; numberofpages:8; journal:BRITISH JOURNAL OF CANCER; http://hdl.handle.net/11568/759619Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84920655625; http://www.nature.com/bjc/index.htmlTest
الإتاحة: https://doi.org/10.1038/bjc.2014.555Test
http://hdl.handle.net/11568/759619Test
http://www.nature.com/bjc/index.htmlTest -
2دورية أكاديمية
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Onkoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı., orcid:0000-0002-9732-5340, Çubukçu, Erdem, Ölmez, Ömer Fatih, Saraydaroǧlu, Özlem, Akçalı, Ünsal, Kanat, Özkan, Kurt, Ender, Evrensel, Türkkan, Manavoǧlu, Osman, AAJ-1027-2021, AAH-9701-2021, 53986153800, 26435400000, 15074395500, 16027743900, 55881548500, 7006207332, 6603942124, 6602587152
مصطلحات موضوعية: Oncology, Non-small-cell lung cancer, Excision repair cross-complementing 1, Immunohistochemistry, Prognosis, Dna-repair, Chemotherapy, Messenger-RNA, Biomarkers, Resistance, Therapy, Gene, Adult, Aged, Antineoplastic agents, Carcinoma, non-small-cell lung, adjuvant, Cisplatin, Disease-free survival, DNA-binding proteins, Endonucleases, Female, Humans, Lung neoplasms, Male, Middle aged, DNA Repair, Value of Repair, Ribonucleotide Reductases
العلاقة: Makale - Uluslararası Hakemli Dergi; Clinical and Translational Oncology; Çubukçu, E. vd. (2011). ''Immunohistochemical expression of excision repair cross-complementing 1 (ERCC1) in non-small-cell lung cancer: Implications for patient outcome''. Clinical and Translational Oncology, 13(11), 826-830.; https://doi.org/10.1007/s12094-011-0741-7Test; https://link.springer.com/article/10.1007/s12094-011-0741-7Test; http://hdl.handle.net/11452/24546Test; 000297518700012; 2-s2.0-84856052532; 826; 830; 13; 11
-
3دورية أكاديمية
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Onkoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı., orcid:0000-0002-9732-5340, Çubukçu, Erdem, Ölmez, Ömer Fatih, Saraydaroǧlu, Özlem, Akçalı, Ünsal, Kanat, Özkan, Kurt, Ender, Evrensel, Türkkan, Manavoǧlu, Osman, AAJ-1027-2021, AAH-9701-2021, 53986153800, 26435400000, 15074395500, 16027743900, 55881548500, 7006207332, 6603942124, 6602587152
مصطلحات موضوعية: Oncology, Non-small-cell lung cancer, Excision repair cross-complementing 1, Immunohistochemistry, Prognosis, Dna-repair, Chemotherapy, Messenger-RNA, Biomarkers, Resistance, Therapy, Gene, Adult, Aged, Antineoplastic agents, Carcinoma, non-small-cell lung, adjuvant, Cisplatin, Disease-free survival, DNA-binding proteins, Endonucleases, Female, Humans, Lung neoplasms, Male, Middle aged, DNA Repair, Value of Repair, Ribonucleotide Reductases
العلاقة: Makale - Uluslararası Hakemli Dergi; Clinical and Translational Oncology; Çubukçu, E. vd. (2011). ''Immunohistochemical expression of excision repair cross-complementing 1 (ERCC1) in non-small-cell lung cancer: Implications for patient outcome''. Clinical and Translational Oncology, 13(11), 826-830.; https://doi.org/10.1007/s12094-011-0741-7Test; https://link.springer.com/article/10.1007/s12094-011-0741-7Test; http://hdl.handle.net/11452/24546Test; 000297518700012; 2-s2.0-84856052532; 826; 830; 13; 11
-
4دورية أكاديمية
المؤلفون: Zucali, Paolo A., Lorenzi, Elena, Merino, Maria, Cao, Liang, Di Tommaso, Luca, Lee, Hye Seung, Incarbone, Matteo, Walter, Beatriz A., Simonelli, Matteo, Roncalli, Massimo, Santoro, Armando, Giaccone, Giuseppe, PETRINI, IACOPO
المساهمون: Zucali, Paolo A., Petrini, Iacopo, Lorenzi, Elena, Merino, Maria, Cao, Liang, Di Tommaso, Luca, Lee, Hye Seung, Incarbone, Matteo, Walter, Beatriz A., Simonelli, Matteo, Roncalli, Massimo, Santoro, Armando, Giaccone, Giuseppe
مصطلحات موضوعية: Expression, Immunohistochemistry, Insulin-like growth factor-1 receptor, Prognosi, Thymoma, Adult, Aged, 80 and over, Female, Human, Male, Middle Aged, Oncogene Protein v-akt, Phosphorylation, Receptor, IGF Type 1, Serine, Thymus Neoplasm, Treatment Outcome, Cancer Research, Oncology
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/20597130; info:eu-repo/semantics/altIdentifier/wos/WOS:000282910800008; volume:116; issue:20; firstpage:4686; lastpage:4695; numberofpages:10; journal:CANCER; http://hdl.handle.net/11568/757344Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-77957569631
-
5
المؤلفون: Gamucci, Teresa, Vitale, Ilio, De Maria Marchiano, Ruggero
المساهمون: Vici, Patrizia, Di Benedetto, Anna, Ercolani, Cristiana, Pizzuti, Laura, Di Lauro, Luigi, Sergi, Domenico, Sperati, Francesca, Terrenato, Irene, Dattilo, Rosanna, Botti, Claudio, Fabi, Alessandra, Ramieri, Maria Teresa, Mentuccia, Lucia, Marinelli, Camilla, Iezzi, Laura, Gamucci, Teresa, Natoli, Clara, Vitale, Ilio, Barba, Maddalena, Mottolese, Marcella, De Maria Marchiano, Ruggero, Maugeri-Saccà, Marcello
مصطلحات موضوعية: DNA damage and repair, Pathological complete response, Triple-negative breast cancer, Adult, Aged, Antineoplastic Combined Chemotherapy Protocol, Biomarkers, Tumor, Checkpoint Kinase 1, Chemotherapy, Adjuvant, DNA Damage, DNA Repair, Drug Resistance, Neoplasm, Female, Histone, Human, Immunohistochemistry, Middle Aged, Neoadjuvant Therapy, Phosphorylation, Predictive Value of Test, Protein Kinase, Retrospective Studie, Treatment Outcome, Triple Negative Breast Neoplasm, Oncology, Settore MED/04 - PATOLOGIA GENERALE
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26544894; info:eu-repo/semantics/altIdentifier/wos/WOS:000369907900030; volume:6; issue:40; firstpage:42773; lastpage:42780; numberofpages:8; issueyear:2015; journal:ONCOTARGET; http://hdl.handle.net/10807/112054Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84952342480; http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=6001&path%5B%5D=16176Test
الإتاحة: https://doi.org/10.18632/oncotarget.6001Test
http://hdl.handle.net/10807/112054Test
http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=6001&path%5B%5D=16176Test